My Cart

DDR1

DDR1 Overview

English NameDiscoidin domain receptor 1Approved Drugs0
Drugs in Clinical Trials5Target SynonymEpithelial discoidin domain-containing receptor 1,Epithelial discoidin domain receptor 1,CD167 antigen-like family member A,Cell adhesion kinase,Discoidin receptor tyrosine kinase,HGK2,Mammary carcinoma kinase 10,MCK-10,Protein-tyrosine kinase 3A,Protein-tyrosine kinase RTK-6,TRK E,Tyrosine kinase DDR,Tyrosine-protein kinase CAK,CD167a,CD167 Antigen-Like Family Member A,TRKE,RTK6,PTK3A Protein Tyrosine Kinase 3A,PTK3A,NTRK4,Neurotrophic Tyrosine Kinase, Receptor, Type 4,Neuroepithelial Tyrosine Kinase,NEP,MCK10,EDDR1,Discoidin Domain Receptor Tyrosine Kinase 1,Discoidin Domain Receptor Family, Member 1,CD167a Antigen,CAK,CD167
Highest Development StagePhase 2 Clinical
English NameDiscoidin domain receptor 1
Target SynonymEpithelial discoidin domain-containing receptor 1,Epithelial discoidin domain receptor 1,CD167 antigen-like family member A,Cell adhesion kinase,Discoidin receptor tyrosine kinase,HGK2,Mammary carcinoma kinase 10,MCK-10,Protein-tyrosine kinase 3A,Protein-tyrosine kinase RTK-6,TRK E,Tyrosine kinase DDR,Tyrosine-protein kinase CAK,CD167a,CD167 Antigen-Like Family Member A,TRKE,RTK6,PTK3A Protein Tyrosine Kinase 3A,PTK3A,NTRK4,Neurotrophic Tyrosine Kinase, Receptor, Type 4,Neuroepithelial Tyrosine Kinase,NEP,MCK10,EDDR1,Discoidin Domain Receptor Tyrosine Kinase 1,Discoidin Domain Receptor Family, Member 1,CD167a Antigen,CAK,CD167
Approved Drugs0
Drugs in Clinical Trials5
Highest Development StagePhase 2 Clinical

DDR1 Product List

  • Product Category

    Protein (3)

  • Product Status

    Launched (3)

  • Species

    Human (2)Mouse (1)

  • Tag

    Fc Tag (2)His Tag & Avi Tag (1)

  • Conjugate

    Unconjugated (2)Biotin-labeled (1)

DDR1 Background

Discoidin domain receptor 1 (DDR1) is a member of DDRs, which are members of the receptor tyrosine kinase (RTK). Upon collagen binding, DDR1 undergoes tyrosine autophosphorylation, which consequently triggers downstream genetic and cellular pathways and plays critical roles in the regulation of cellular morphogenesis, differentiation, proliferation, adhesion, migration, and invasion. Research shows that DDR1 is closely related to various human diseases including cancer, fibrosis, atherosclerosis, and other inflammatory disorders. New generation DDR1 inhibitors targeting the allosteric sites outside of the canonical ATP-binding pocket or extracellular domain (allosteric inhibitors) may offer a new opportunity for selective DDR1 inhibition therapy development.

DDR1 Synonyms

CD167a

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Merestinib5OGS5K699E; LY-2801653Phase 2 ClinicalEli Lilly And CompanyBiliary Tract Neoplasms; Solid tumours; Skin Melanoma; Bone metastases; Pancreatic Neoplasms; Neoplasms; Microsatellite instability-high cancer; Breast Neoplasms; Cholangiocarcinoma; Lymphoma, Mantle-Cell; Colorectal Neoplasms; Gallbladder Neoplasms; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung
Details
PRTH-101PRTH-101Phase 1 ClinicalThe George Washington University Milken Institute School Of Public Health (Gwu), Parthenon Therapeutics IncSolid tumours; Neoplasms
Details
ICP-033ICP-033Phase 1 ClinicalBeijing Innocare Pharma Tech Co LtdSolid tumours
Details
AVI-4015AVI-4015Phase 1 ClinicalAvixgenDry Eye Syndromes
Details
AGX-0073AGX-0073Phase 1 ClinicalShanghai Aojian Biological Technology Co LtdSolid tumours
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland